Hypertriglyceridemia Clinical Trials

A Phase 3, Multi-Center, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study With a 40-Week, Active-Controlled, Open-Label Extension to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting Triglyceride Levels =500 mg/dL and <2000 mg/dL and Mild or Moderate Renal Impairment

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

A research study is evaluating an investigational medication to see if it lowers high triglycerides.  

The purpose of this study is to determine whether CaPre® 4g daily can help lower fasting triglyceride (a kind of fat in the blood) levels. The safety and tolerability of CaPre® will also be assessed. In addition, this study will compare CaPre® 4g daily with placebo, a substance that looks like ...

The TRILOGY 1 Study is looking at an investigational medication to see how safe it is, and how well it works, to help reduce triglyceride levels. Triglycerides are a type of fat that can be found in your blood. At high levels, triglycerides can cause problems with your heart, blood ...

This is a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, including tolerability, of ISIS 703802 and to assess the efficacy of different doses and dosing regimens of ISIS 703802 on glucose and lipid metabolism, and liver fat in subjects with Hypertriglyceridemia, Type 2 Diabetes Mellitus (T2DM), and ...

This is a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, including tolerability, of ISIS 678354 and to assess the efficacy of different doses and dosing regimens of ISIS 678354 for reduction of serum triglyceride (TG) levels in patients with hypertriglyceridemia and established CVD.  

A clinical research study is underway for those who have been diagnosed with Type 2 diabetes, have high Triglycerides, low HDL cholesterol “good cholesterol”, and are at risk for future cardiovascular events. The main goal of this study is to learn, if a potential new medication can help prevent heart ...

Don't wait, participate! A clinical trial for high triglycerides is now enrolling in Gurnee, Illinois. Play an active role in your health care and contact us to see if you qualify to participate.

Don't wait, participate! A clinical trial for people with type 2 diabetes, who also have high triglycerides and low, good cholesterol is now enrolling.  Play an active role in your health care and contact us to see if you qualify to participate in this study.